Search results for “Pulmonary Cancers” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 2,427 patents, we discovered top 460 key players by total patent application. Genentech, Inc., F. Hoffmann-La Roche Ltd., Immatics Biotechnologies GmbH are dominant in this area. They take 9.68% of the total patent filing.
California, United States
Patent: 83
Switzerland
Patent: 82
Baden-Württemberg, Germany
Patent: 70
Basel-Stadt, Switzerland
Patent: 64
Jiangsu Sheng, China
Patent: 57
Hessen, Germany
Patent: 56
Jiangsu Sheng, China
Patent: 45
California, United States
Patent: 41
New York, United States
Patent: 38
Indiana, United States
Patent: 35
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 77 patents, we discovered top 22 start-ups by total patent application. ALX Oncology, Inc., Combined Therapeutics, Inc., Ervaxx Ltd. are active in this area.
STARTUP
California, United States
Patent: 15
STARTUP
Massachusetts, United States
Patent: 10
STARTUP
United Kingdom
Patent: 10
STARTUP
Guangdong Sheng, China
Patent: 8
STARTUP
South Korea
Patent: 6
STARTUP
Shanghai Shi, China
Patent: 5
STARTUP
Osaka-fu, Japan
Patent: 3
Illinois, United States
Patent: 2
California, United States
Patent: 2
STARTUP
Massachusetts, United States
Patent: 2
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 2,053 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing F. Hoffmann-La Roche Ltd., Genentech, Inc., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. take 7.16% of patent filing during this period.
Switzerland
Patent: 52
California, United States
Patent: 50
Jiangsu Sheng, China
Patent: 45
Jiangsu Sheng, China
Patent: 43
Baden-Württemberg, Germany
Patent: 39
New York, United States
Patent: 30
Guangdong Sheng, China
Patent: 26
New York, United States
Patent: 25
Hessen, Germany
Patent: 25
Madrid, Spain
Patent: 20
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 2,053 patents in last 5 years, we discover 389 new entrants. Shenzhen Chipscreen Biosciences Co., Ltd., Iovance Biotherapeutics, Inc., Jiangsu Hengrui Pharmaceuticals Co., Ltd. are the most active new entrants in this area.
Guangdong Sheng, China
Patent: 26
New York, United States
Patent: 25
Jiangsu Sheng, China
Patent: 20
STARTUP
California, United States
Patent: 15
Shanghai Shi, China
Patent: 15
Shanghai Shi, China
Patent: 15
Beijing Shi, China
Patent: 13
New York, United States
Patent: 13
Genmab A/S
Hovedstaden, Denmark
Patent: 13
Jiangsu Sheng, China
Patent: 12
Research Institutions
Order by:
Innovation Intensity
With the analysis among 819 patents, we discovered top 203 universities and scientific research institutions by total patent application. Shanghai Institute of Materia Medica Chinese Academy of Sciences, University of British Columbia, Cornell University are dominant in this area. They take 6.59% of the total patent filing.
Shanghai Shi, China
Patent: 17
British Columbia, Canada
Patent: 15
New York, United States
Patent: 13
Guangdong Sheng, China
Patent: 12
Sichuan Sheng, China
Patent: 12
Jiangsu Sheng, China
Patent: 12
Zhejiang Sheng, China
Patent: 12
Shanghai Shi, China
Patent: 12
Shanghai Shi, China
Patent: 11
Guangdong Sheng, China
Patent: 10
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: